Cutaneous T-Cell Lymphoma Recurrent Terminated Phase 0 Trials for Pegaspargase (DB00059)

Also known as: T-Cell Lymphoma Relapsed / Recurrent T-Cell Lymphoma / Recurrent Cutaneous T-cell lymphoma / T-cell lymphoma recurrent / Relapsed T-Cell Lymphoma / T-cell lymphoma NOS recurrent

IndicationStatusPhase
DBCOND0136063 (Cutaneous T-Cell Lymphoma Recurrent)Terminated0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01878708A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell LymphomaTreatment